Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
A new study is the latest to find no evidence that GLP-1 drugs like Ozempic increase the risk of suicide.
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol and cocaine.
A new case series links GLP-1 use to three different eye conditions, all of which can lead to blindness.
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like Ozempic.
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether someone has obesity, alongside other major changes.
A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.
Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden vision loss.
MIT engineers have revealed a new gastric balloon design that can inflate on demand to make you feel full before meals.
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be adapted into treatments for substance use disorders.
New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.
Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.
A new survey shows that most people would rather try dieting to lose weight than take the latest injectable drugs like Ozempic.
New research suggests GLP-1 medications can blunt people's cravings for potentially addictive substances like opioids.
The rate of adult obesity has finally stopped climbing in recent years, new CDC data shows.
Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect our body? And what's left to learn?
Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.
GLP-1 drugs are effective weight loss tools, but exactly how they work is still mysterious.
